These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23722017)

  • 1. Beclin 1 and bcl-2 expressions in bladder urothelial tumors and their association with clinicopathological parameters.
    Baspinar S; Bircan S; Yavuz G; Kapucuoglu N
    Pathol Res Pract; 2013 Jul; 209(7):418-23. PubMed ID: 23722017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relation of beclin 1 and bcl-2 expressions in high grade prostatic intraepithelial neoplasia and prostate adenocarcinoma: a tissue microarray study.
    Baspinar S; Bircan S; Orhan H; Kapucuoglu N; Bozkurt KK
    Pathol Res Pract; 2014 Jul; 210(7):412-8. PubMed ID: 24690321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GATA3 immunohistochemistry in urothelial carcinoma of the upper urinary tract as a urothelial marker and a prognosticator.
    Inoue S; Mizushima T; Fujita K; Meliti A; Ide H; Yamaguchi S; Fushimi H; Netto GJ; Nonomura N; Miyamoto H
    Hum Pathol; 2017 Jun; 64():83-90. PubMed ID: 28428106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Connexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancer.
    Poyet C; Buser L; Roudnicky F; Detmar M; Hermanns T; Mannhard D; Höhn A; Rüschoff J; Zhong Q; Sulser T; Moch H; Wild PJ
    J Clin Pathol; 2015 Oct; 68(10):819-24. PubMed ID: 26251520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of beclin-1, an autophagic gene, in hepatocellular carcinoma associated with clinical pathological and prognostic significance.
    Qiu DM; Wang GL; Chen L; Xu YY; He S; Cao XL; Qin J; Zhou JM; Zhang YX; E Q
    BMC Cancer; 2014 May; 14():327. PubMed ID: 24885292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of Ki67, TP53, MDM-2 and BCL-2 expressions with WHO 1973 and WHO/ISUP grades, tumor category and overall patient survival in urothelial tumors of the bladder.
    Gönül II; Akyürek N; Dursun A; Küpeli B
    Pathol Res Pract; 2008; 204(10):707-17. PubMed ID: 18572327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of the reduction of UT-B expression in urothelial carcinoma of the bladder.
    Li C; Xue H; Lei Y; Zhu J; Yang B; Gai X
    Pathol Res Pract; 2014 Dec; 210(12):799-803. PubMed ID: 25445116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of transcription factor Twist1 in bladder urothelial carcinoma and its clinical significance.
    Tang X; Xing J; Li W; Wu Z; Zhang K; Zheng J
    J BUON; 2013; 18(1):211-9. PubMed ID: 23613408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD 10 expression intensity in various grades and stages of urothelial carcinoma of urinary bladder.
    Atique M; Abbasi MS; Jamal S; Khadim MT; Akhtar F; Jamal N
    J Coll Physicians Surg Pak; 2014 May; 24(5):351-5. PubMed ID: 24848395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical determination of ETS-1 oncoprotein expression in urothelial carcinomas of the urinary bladder.
    Sari A; Calli A; Gorgel SN; Altinboga AA; Kara C; Dincel C; Cakalagaoglu F
    Appl Immunohistochem Mol Morphol; 2012 Mar; 20(2):153-8. PubMed ID: 21623185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingosine-1-phosphate receptor 1 (S1PR1) expression in non-muscle invasive urothelial carcinoma: Association with poor clinical outcome and potential therapeutic target.
    Go H; Kim PJ; Jeon YK; Cho YM; Kim K; Park BH; Ku JY
    Eur J Cancer; 2015 Sep; 51(14):1937-45. PubMed ID: 26238015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the endothelin axis in noninvasive and superficially invasive bladder cancer: relation to clinicopathologic and molecular prognostic parameters.
    Eltze E; Wild PJ; Wülfing C; Zwarthoff EC; Burger M; Stoehr R; Korsching E; Hartmann A
    Eur Urol; 2009 Nov; 56(5):837-45. PubMed ID: 18945538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic correlation of autophagy-related Beclin-1 expression in gallbladder cancer.
    Park JY; Kim HS; Cho H; Kim NC; Chae KH; Park WS; Kim YW
    Hepatogastroenterology; 2014 Sep; 61(134):1494-500. PubMed ID: 25436332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein expression and amplification of AIB1 in human urothelial carcinoma of the bladder and overexpression of AIB1 is a new independent prognostic marker of patient survival.
    Luo JH; Xie D; Liu MZ; Chen W; Liu YD; Wu GQ; Kung HF; Zeng YX; Guan XY
    Int J Cancer; 2008 Jun; 122(11):2554-61. PubMed ID: 18246597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXO1 down-regulation is associated with worse outcome in bladder cancer and adds significant prognostic information to p53 overexpression.
    Lloreta J; Font-Tello A; Juanpere N; Frances A; Lorenzo M; Nonell L; de Muga S; Vázquez I; Cecchini L; Hernández-Llodrà S
    Hum Pathol; 2017 Apr; 62():222-231. PubMed ID: 28087474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cell cycle proteins in T1a and T1b urothelial bladder carcinoma and their value in predicting tumor progression.
    Mhawech P; Greloz V; Oppikofer C; Szalay-Quinodoz I; Herrmann F
    Cancer; 2004 Jun; 100(11):2367-75. PubMed ID: 15160340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of bcl-2 and bcl-X in bladder cancer.
    Kirsh EJ; Baunoch DA; Stadler WM
    J Urol; 1998 Apr; 159(4):1348-53. PubMed ID: 9507882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bcl-2 predicts response to neoadjuvant chemotherapy and is overexpressed in lymph node metastases of urothelial cancer of the bladder.
    Kiss B; Skuginna V; Fleischmann A; Bell RH; Collins C; Thalmann GN; Seiler R
    Urol Oncol; 2015 Apr; 33(4):166.e1-8. PubMed ID: 25596645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic correlation of beclin-1 and bcl-2 expression in human breast cancer.
    Won KY; Kim GY; Kim YW; Song JY; Lim SJ
    Hum Pathol; 2010 Jan; 41(1):107-12. PubMed ID: 19762066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased RECK and Increased EMMPRIN expression in urothelial carcinoma of the bladder are associated with tumor aggressiveness.
    Wittschieber D; Stenzinger A; Klauschen F; Stephan C; Jung K; Erbersdobler A; Rabien A
    Pathobiology; 2011; 78(3):123-31. PubMed ID: 21613799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.